New balloon coated with drug aims to keep leg arteries open longer
NCT ID NCT06832631
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 284 people with blocked leg arteries (peripheral arterial disease) who are treated with a paclitaxel-coated balloon. The balloon is inflated inside the artery to open it and release a drug that helps prevent it from narrowing again. Researchers are tracking safety and how well the artery stays open over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
paclitaxel-coated balloon
What this could lead to
If successful, this could confirm that the paclitaxel-coated balloon is a safe and effective way to open blocked leg arteries and reduce the need for repeat procedures.
What could go wrong
This is an observational registry, not a randomized trial, so results may be less definitive. The drug coating may carry risks like inflammation or late complications, and long-term benefits are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Groennge
Kortrijk, 3000, Belgium
-
AZ Jan Portaels
Vilvoorde, 1800, Belgium
-
AZ Sint-Blasius
Dendermonde, 9200, Belgium
-
AZORG
Aalst, 9300, Belgium
-
Complejo Hospitalario Universitario de Ourense
Ourense, 32005, Spain
-
Hospital General de Granollers
Granollers, 08402, Spain
-
Hospital Universitario de Cabueñes
Gijón, 33394, Spain
-
Hospital Universitario de Toledo
Toledo, 45007, Spain
-
Klinikum Lippe Detmold
Detmold, 32756, Germany
-
RZ Heilig Hart Tienen
Tienen, 3300, Belgium
-
SRH Klinikum Karlsbad-Langensteinbach GmbH
Karlsbad, 76307, Germany
-
Singapore General Hospital
Singapore, 169608, Singapore
-
ZOL Genk
Genk, 3600, Belgium